IMUX Financials

Immunic Inc - Financial statements & key metrics

Stock Price

$1.00

Market Cap

$130.46M

EPS

$-0.62

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

Gross Profit

Operating Income

Net Income

$-100.51M

EPS (Diluted)

$-1.00

Balance Sheet Highlights

Total Assets

$40.87M

Total Liabilities

$22.44M

Shareholders Equity

Cash & Equivalents

$35.67M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-84.77M

CapEx

Free Cash Flow

Profitability Metrics

ROE

-16.5%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is IMUX revenue?

View IMUX's income statement for detailed revenue data.

Is IMUX profitable?

IMUX reported a loss of $100.51M in the most recent quarter.

What is IMUX market cap?

IMUX has a market capitalization of $130.46M, making it a small-cap stock.

Does IMUX have debt?

View IMUX's balance sheet for debt information.

What is IMUX cash flow?

Cash flow data is available in the full financial statements.